Evaluation of replacing the existing diagnostic strategy for Neisseria gonorrhoeae and Chlamydia trachomatis infections with sole molecular testing of urine specimens in a sexually transmitted infection clinic setting

Sexually Transmitted Infections

Volumn 85, Issue 5, 2009, Pages 322-325

  Ho, Man K ^a,b   Lo, J Y C ^a   Lo, A C T ^a   Cheng, F K ^a   Chan, F K ^a  

^a DEPARTMENT OF HEALTH   (Hong Kong)

^b Fanling Integrated Treatment Centre (Social Hygiene Service)   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTIBUTEN;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL EVALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; GONORRHEA; GRAM STAINING; HUMAN; INOCULATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MICROSCOPY; NEISSERIA GONORRHOEAE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASE; URINALYSIS;

AMBULATORY CARE FACILITIES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HONG KONG; HUMANS; MALE; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

EID: 70349330804     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2008.035220     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 2006;55:1-100.
2. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae. WHO/CDS/CSR/DRS/2001.3. Geneva: World Health Organization, 2001.
3. World Health Organisation. Laboratory diagnosis of gonorrhoea. New Delhi: World Health Organization, 1999.
4. Boyadzhyan B, Yashina T, Yatabe JH, et al. Comparison of the APTIMA CT and GC assays with the APTIMA Combo 2 assay, the Abbott LCx Assay, and direct fluorescent-antibody and culture assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J Clin Microbiol 2004;42:3089-3093 (Pubitemid 38938063)
5. Moncada J, Schachter J, Hook EW III, et al. The effect of urine testing in evaluations of the sensitivity of the Gen-Probe Aptima Combo 2 assay on endocervical swabs for Chlamydia trachomatis and Neisseria gonorrhoeae: the infected patient standard reduces sensitivity of single site evaluation. Sex Transm Dis 2004;31:273-277 (Pubitemid 38542655)
6. Blake DR, Maldeis N, Bernes MR, et al. Cost-effectiveness of screening strategies for Chlamydia trachomatis using cervical swabs, urine, and self-obtained vaginal swabs in a sexually transmitted disease clinic setting. Sex Transm Dis 2008;37:649-655
7. Lavelle SJ, Jones KE, Mallinson H, et al. Finding, confirming, and managing gonorrhoea in a population screened for chlamydia using the Gen-Probe Aptima Combo2 assay. Sex Transm Infect 2006;82:221-224 (Pubitemid 43901590)
8. Carroll KC, Aldeen WE, Morrison M, et al. Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J Clin Microbiol 1998;36:1630-1633 (Pubitemid 28226044)
9. Lowe P, O'Loughlin P, Evans K, et al. Comparison of the Gen-Probe APTIMA Combo 2 assay to the AMPLICOR CT/NG assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine samples from Australian men and women. J Clin Microbiol 2006;44:2619-2621 (Pubitemid 44092444)
10. Levett PN, Brandt K, Olenius K, et al. Evaluation of three automated nucleic acid amplification systems for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in first-void urine specimens. J Clin Microbiol 2008;46:2109-2111 (Pubitemid 351831856)
11. Chernesky M, Jang D, Luinstra K, et al. High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay. J Clin Microbiol 2006;44:400-405 (Pubitemid 43222230)
12. Moss S, Mallinson H. The contribution of APTIMA Combo 2 assay to the diagnosis of gonorrhoea in genitourinary medicine setting. Int J STD AIDS 2007;18:551-554 (Pubitemid 351738944)
13. O'Mahony C, Reeve-Fowkes A, Worthen E, et al. Three years of using Aptima Combo 2 (AC2) transcription-mediated amplification for gonorrhoea in a district hospital genitourinary medicine clinic shows it to be superior to culture and has a specificity of almost 100%. Int J STD AIDS 2008;19:67-69 (Pubitemid 351738852)
14. Schachter J, Chernesky MA, Willis DE, et al. Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: results from a multicenter evaluation of the APTIMA assays for both infections. Sex Transm Dis 2005;32:725-728 (Pubitemid 41752557)